Mohr Erich 4
4 · DelMar Pharmaceuticals, Inc. · Filed Oct 2, 2017
Insider Transaction Report
Form 4
Mohr Erich
Director
Transactions
- Other
Common Stock
2017-09-29$3.20/sh+528$1,690→ 7,166 total
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.